Rising infectious disease cases are driving growth in the rapid diagnostics market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Rapid Diagnostics Market Grow Between 2026 And 2030?

The rapid diagnostics market has shown considerable growth in recent years. This market is expected to expand from $36.08 billion in 2025 to $40.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. The expansion observed historically is attributable to an increasing demand for faster clinical diagnostics, the expansion of decentralized healthcare settings, a rising prevalence of chronic and infectious diseases, enhanced accessibility of diagnostic tools, and the growth of outpatient diagnostic services.

The rapid diagnostics market is projected for substantial expansion over the upcoming years. Its valuation is set to reach $64.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. This projected increase is driven by factors such as heightened investments in molecular diagnostics, the increasing uptake of connected diagnostic tools, the broadening availability of home-based testing options, a growing emphasis on personalized diagnostics, and the expanded application of data-driven clinical processes. Key trends anticipated during this period encompass the wider utilization of point-of-care diagnostic platforms, a rise in the adoption of molecular rapid testing, the growing incorporation of digital interpretation for results, an expansion in portable diagnostic instrumentation, and a sharpened focus on providing early clinical decision support.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24679&type=smp

What Key Factors Are Affecting The Rapid Diagnostics Market Demand?

The growing occurrence of infectious diseases is anticipated to drive expansion in the rapid diagnostics market moving ahead. An infectious disease is defined as an illness stemming from disease-causing microorganisms like bacteria, viruses, parasites, or fungi, capable of transmitting between individuals either directly or indirectly. The escalating spread of infectious diseases is fueled by increased international travel, leading to quicker transmission and elevated infection rates. Rapid diagnostics assist in managing infectious diseases through the swift and precise identification of pathogens, facilitating prompt treatment choices, decreased transmission, and better patient results. For example, in May 2025, The World Health Organization (WHO), the Switzerland-based specialized agency of the United Nations for international public health, reported that global SARS-CoV-2 (the virus causing COVID-19, an infectious disease) activity had been increasing since mid-February 2025, according to sentinel site data, with its test positivity rate reaching 11%, a figure not seen since July 2024. Consequently, the rising occurrence of infectious diseases is a significant driver for the rapid diagnostics market.

What Segment Categories Shape The Rapid Diagnostics Market Segment Landscape?

The rapid diagnostics market covered in this report is segmented –

1) By Product Type: Kits, Reagents, Instruments, Other Product Types

2) By Platform: Immunoassays, Molecular Detection, Other Rapid Diagnostic Platforms

3) By Application: Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing

4) By Distribution Channel: Hospital Pharmacies, Brick and Mortar, E-Commerce, Other Distribution Channels

5) By End Use: Diagnostic Centers, Homecare Settings, Hospital Pharmacies, Other End Users

Subsegments:

1) By Kits: Lateral Flow Assay Kits, PCR Kits, Immunoassay Kits, Microfluidic Kits, Molecular Diagnostic Kits, Multiplex Kits

2) By Reagents: Enzymes, Buffers, Probes and Primers, Stains and Dyes, Antibodies, Calibration and Control Reagents

3) By Instruments: PCR Machines, Lateral Flow Readers, Immunoassay Analyzers, Microfluidic Analyzers, Automated Sample Processors, Biosensors

4) By Other Product Types: Software and Data Management Tools, Sample Collection Devices, Accessories and Consumables, Calibration Standards, Point-of-Care Devices

What Trends Are Influencing Changes In The Rapid Diagnostics Market?

Leading firms within the rapid diagnostics market are prioritizing innovation and technological progress, including rapid diagnostic testing tools, with the aim of boosting diagnostic precision, shortening turnaround periods, and enhancing patient results in point-of-care environments. These rapid diagnostic testing tools are medical devices designed for swift detection of particular diseases or conditions, generally yielding results in minutes at the point of care. An example is in May 2025, SEKISUI Diagnostics, a US-based medical diagnostics producer, introduced the OSOM RSV Test, a rapid diagnostic instrument for identifying respiratory syncytial virus (RSV). This specific test is designed for professional healthcare environments and provides results in just 15 minutes. It utilizes a rapid immunochromatographic assay for the qualitative detection of RSV nucleoprotein antigen. Anterior nasal swab specimens taken from patients exhibiting symptoms of respiratory infection are used for this test. Its prompt turnaround time facilitates timely and effective clinical decision-making.

Who Are The Companies Operating Across The Rapid Diagnostics Market Value Chain?

Major companies operating in the rapid diagnostics market are Johnson And Johnson Services Inc, F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Hologic Inc, bioMerieux SA, QuidelOrtho Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Cepheid Inc, OraSure Technologies Inc, Nova Biomedical Corporation, Fujirebio Holdings Inc, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Abingdon Health plc, Abionic SA, LumiraDx Ltd

Get The Full Rapid Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/rapid-diagnostics-global-market-report

Where Is The Rapid Diagnostics Market Primarily Concentrated By Region?

North America was the largest region in the rapid diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Rapid Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/rapid-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Rapid Diagnostics Market 2026, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Covid 19 Rapid Test Kits Market Report

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

Rapid Strength Concrete Market Report

https://www.thebusinessresearchcompany.com/report/rapid-strength-concrete-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795